BioCentury
ARTICLE | Regulation

White House allows FDA to release long-awaited COVID vaccine EUA guidance 

CBER’s Marks: guidance aimed at increasing public confidence in FDA’s integrity

October 6, 2020 2:40 PM UTC
Updated on Oct 7, 2020 at 5:47 PM UTC

In a move that is intended to bolster public confidence in FDA’s integrity, the agency Tuesday posted guidance about emergency use authorization of COVID-19 vaccines.

FDA posted the guidance after the White House dropped a weeks-long hold it had placed on the document. The White House green light came hours after the agency had bypassed the Trump administration by releasing key provisions from the guidance in a briefing document distributed in advance of an advisory committee meeting...